ECSP034489A - Farmacos para ligandos del receptor nmda - Google Patents
Farmacos para ligandos del receptor nmdaInfo
- Publication number
- ECSP034489A ECSP034489A EC2003004489A ECSP034489A ECSP034489A EC SP034489 A ECSP034489 A EC SP034489A EC 2003004489 A EC2003004489 A EC 2003004489A EC SP034489 A ECSP034489 A EC SP034489A EC SP034489 A ECSP034489 A EC SP034489A
- Authority
- EC
- Ecuador
- Prior art keywords
- pharmacos
- nmda
- ligands
- nmda receiver
- receiver ligands
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 2
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere a compuestos de fórmula general los cuales son de utilidad para el tratamiento de enfermedades relacionadas con el receptor del NMDA.Estos compuestos pueden ser empleados como profármacos para el compuesto madre de fórmula, los cuáles son de utilidad para el tratamiento de enfermedades relacionadas con el receptor del NMDA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117918 | 2000-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034489A true ECSP034489A (es) | 2003-03-31 |
Family
ID=8169594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004489A ECSP034489A (es) | 2000-08-21 | 2003-02-20 | Farmacos para ligandos del receptor nmda |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6407235B1 (es) |
| EP (1) | EP1313703B1 (es) |
| JP (1) | JP4162991B2 (es) |
| KR (1) | KR100589991B1 (es) |
| CN (1) | CN1227230C (es) |
| AR (1) | AR030373A1 (es) |
| AT (1) | ATE386022T1 (es) |
| AU (2) | AU2001285894B2 (es) |
| BR (1) | BR0113348A (es) |
| CA (1) | CA2419279C (es) |
| CY (1) | CY1107937T1 (es) |
| CZ (1) | CZ303319B6 (es) |
| DE (1) | DE60132782T2 (es) |
| DK (1) | DK1313703T3 (es) |
| EC (1) | ECSP034489A (es) |
| EG (1) | EG24293A (es) |
| ES (1) | ES2299508T3 (es) |
| HK (1) | HK1059083A1 (es) |
| HR (1) | HRP20030125B1 (es) |
| HU (1) | HU229802B1 (es) |
| IL (1) | IL154254A0 (es) |
| JO (1) | JO2289B1 (es) |
| MA (1) | MA26947A1 (es) |
| MX (1) | MXPA03001311A (es) |
| MY (1) | MY136065A (es) |
| NO (1) | NO324941B1 (es) |
| NZ (1) | NZ523990A (es) |
| PA (1) | PA8525601A1 (es) |
| PE (1) | PE20020291A1 (es) |
| PL (1) | PL204215B1 (es) |
| PT (1) | PT1313703E (es) |
| RS (1) | RS51467B (es) |
| RU (1) | RU2272027C2 (es) |
| SI (1) | SI1313703T1 (es) |
| WO (1) | WO2002016321A1 (es) |
| ZA (1) | ZA200300894B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK12842002A3 (sk) * | 2000-03-21 | 2003-02-04 | The Procter And Gamble Company | Heterocyklický vedľajší reťazec obsahujúci N-substituované inhibítory metaloproteáz a farmaceutický prípravok s ich obsahom |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| AU2006327892B2 (en) * | 2005-12-19 | 2011-12-22 | Methylgene Inc. | Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| JP2010513326A (ja) | 2006-12-19 | 2010-04-30 | メシルジーン インコーポレイテッド | ヒストンデアセチラーゼの阻害薬及びそのプロドラッグ |
| US8796330B2 (en) * | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| US9822075B2 (en) | 2013-11-05 | 2017-11-21 | Astrazeneca Ab | NMDA antagonist prodrugs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4410822A1 (de) | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| TW498067B (en) | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| TWI254043B (en) | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
-
2001
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active IP Right Cessation
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 EP EP01965201A patent/EP1313703B1/en not_active Expired - Lifetime
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/en active IP Right Grant
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
-
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
-
2004
- 2004-03-16 HK HK04101906A patent/HK1059083A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27551A1 (es) | Derivados de benzotiazol | |
| GT200500296A (es) | Sintesis asimetrica de derivados del dehidrobenzofurano | |
| CY1109088T1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης | |
| UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
| ECSP066447A (es) | Derivados de isoquinolina 1,4-disustituida como inhibidores raf-quinasa útiles para el tratamiento de enfermedades proliferativas | |
| PA8527001A1 (es) | Poliarilcarboxamidas utiles como agentes reductores de lipidos | |
| EA200501504A1 (ru) | Лиганды каннабиноидных рецепторов и их применение | |
| AR018705A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos. | |
| CR20120294A (es) | Compuestos tricíclicos novedosos | |
| GT200500102A (es) | Compuestos de aril-o-heteroarilamida ortosustituidos | |
| EA201690153A1 (ru) | Замещенные бензофуранильные и бензоксазолильные соединения и их применения | |
| HK1080088A1 (zh) | 製備c-7取代的5-雄甾烯的方法 | |
| ECSP034428A (es) | Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso | |
| CO6382083A2 (es) | Compuestos triciclicos novedosos | |
| CR11429A (es) | Derivados bis-(sulfonilamino) en terapia 066 | |
| PA8524401A1 (es) | DERIVADOS DE 4-Fenil-piridin | |
| UY27026A1 (es) | Derivados benzodiacepínicos como moduladores de los receptores gaba a | |
| CR8437A (es) | Derivados de oxazol de tetraciclina | |
| SV2010003501A (es) | Fungicidas novedosos | |
| NO20074047L (no) | Ny fremgangsmate for fremstilling av substituerte indoler | |
| DK1670778T3 (da) | Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende | |
| SV2004001250A (es) | Agonistas muscarinicos ref, x - 15335 | |
| ECSP045396A (es) | Proceso para preparar derivados de 6-alquiliden penem | |
| ECSP034489A (es) | Farmacos para ligandos del receptor nmda | |
| ES2159488B1 (es) | Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica. |